The Intel Health Guide, which received 510(k) market clearance from the United States Food and Drug Administration (FDA) in July, is a comprehensive personal health system that combines an in-home patient device - the Intel Health Guide PHS6000 - as well as an on-line interface - the Intel Health Care Management Suite - allowing clinicians to monitor patients in their homes and manage care remotely. The Intel Health Guide is a regulated device that already carries the CE mark under the European Union Medical Device Directive. Additional localised European language versions of the Intel Health Guide will be announced throughout 2009.
"The Health Guide is a step forward in offering more personalized and effective management of chronic health conditions in the home", stated Louis Burns, vice president and general manager of the Intel Digital Health Group. "Intel has spent years researching the needs of both caregivers and patients, and we are now moving to launch a series of products that will help extend care from the hospital to the home. Our products will help address the challenges of an aging population and rising rates of chronic disease."
Intel is collaborating with health care industry experts around the world to validate the clinical benefits of the Health Guide for a wide range of chronic disease conditions and health and wellness applications. Pilot studies in the United States are currently planned with health care organisations such as Aetna, Erickson Retirement Communities, Providence Medical Group in Oregon and SCAN Health Plan. The goals and objectives are to assess how the Health Guide integrates with different care management models in the home. These first studies focus on the ability to demonstrate improved health outcomes for conditions such as heart failure, diabetes, hypertension and chronic obstructive pulmonary disease.
Customers such as Advanced Warning Systems Inc. (AWS), a provider of health care discovery products and web-based services, monitor people for acute cardiovascular symptoms that can cause sudden death. AWS will use the Intel Heath Guide to connect with a targeted class of users, including retired athletes and post-war veterans suffering from post traumatic stress disorder (PTSD), with the highest incidence of cardiovascular related illnesses.
The Health Guide promotes greater patient engagement and more efficient care management by enabling communication between patients and health care professionals and providing clinicians with access to the most current, actionable data. This solution offers interactive tools for personalized care management and includes vital sign collection, patient reminders, surveys, multimedia educational content, and feedback and communications tools, such as video conferencing and alerts. Clinicians have ongoing access to data so that they can better manage each patient's conditions while patients benefit from customized care in the comfort of their own living room.
Intel is working with major health care organisations that have an understanding of health care delivery to develop unique patient care plans as well as multimedia educational content for chronic conditions. Specifically, Intel is working with the Mayo Clinic to have licensed educational content from MayoClinic.com made available to customers using the Health Guide.
In addition, Intel is working with the American Heart Association to create care plans based on the organisation's treatment guidelines for a pilot project for the ongoing management of patients with heart failure. The intent is to help health care professionals monitor patients and remotely manage their care in accordance with science guidelines and also to provide patients with ready access to credible and targeted education material. Intel has also hired a team of clinical experts to provide a range of professional services to enable health care organisations to successfully integrate the personal health system into their current disease management programmes and models of care.
Additionally, Intel plans to use the core technology components of the solution to build products targeted for new areas such as independent living and programmes for health and wellness management and to support new devices such as mobile phones and handhelds.
American Medical Alert Corporation, a national provider of remote patient monitoring devices and 24/7 health care communication services, will be the first United States market channel partner for the Intel Health Guide. By adding the Intel Health Guide to its portfolio of offerings, AMAC will be further equipped to provide its customers with the best in care management technologies. The Health Guide is designed to be used by health care professionals to manage their patients at home and is not currently available for general consumer purchase.
European pilots are under way with health care organisations such as NHS Lothian, United Kingdom, the Institute for Prevention and Telemedicine (IPT) and the Academic Medical Center (AMC), Amsterdam, The Netherlands. Martin Egan, Director of eHealth, NHS Lothian, stated: "We are delighted to be at the heart of this pioneering work through our pilot programme. Initial findings show that patients experience additional reassurance from the telehealth system and the early indications around the reduction of hospital admissions look promising. We are now working toward the expansion of the programme across Lothian."
The pilot in The Netherlands is a co-operative effort between the Academic Medical Center (AMC) in Amsterdam, the Institute for Prevention and Telemedicine (IPT) and Intel. The project involves cardiologists and patients from the congestive heart failure (CHF) outpatient clinic of the AMC under the supervision of Professor Bas de Mol, Head of the Department of Cardiothoracic Surgery.
In the United Kingdom, Intel has worked with the Map of Medicine and using their existing pathways developed care plans for use on the Intel Health Guide that are based on best practice and evidence to help patients and their clinicians effectively manage their condition at home. Care plans were developed for a number of chronic conditions including diabetes, heart failure and COPD.
Tunstall Healthcare Group, a provider of telecare and telehealth solutions, is the first official market channel partner for the Intel Health Guide in the United Kingdom. James Buckley, Tunstall CEO, stated: "By adding the Intel Health Guide to our portfolio of health care offerings, Tunstall will be further equipped to provide its customers with the best in care management solutions." Intel is also currently working with other market channel partners in the United Kingdom to bring the Intel Health Guide to market.
More Intel news is available in the VMW August 2008 article Intel receives FDA market clearance on in-home medical device for management of health conditions.